Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species

被引:16
作者
Nguyen, MH
Clancy, CJ
Yu, YC
Lewin, AS
机构
[1] Univ Florida, Coll Med, J Hillis Miller Hlth Ctr, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, J Hillis Miller Hlth Ctr, Dept Mol Genet, Gainesville, FL 32610 USA
[3] Vet Affairs Med Ctr, Dept Med, Gainesville, FL 32608 USA
关键词
D O I
10.1007/BF01700417
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The potential role of azithromycin in combination with amphotericin B against 25 clinical isolates of Aspergillus was assessed, The MIC of amphotericin B was 1 mu g/ml for 44% of the isolates, 0.5 mu g/ml for 48%, and 0.25 mu gl/ml for 8%, All isolates were resistant to azithromycin. Synergism, defined as a greater than or equal to twofold reduction in the MIC of both drugs upon combination, was demonstrated between amphotericin B and azithromycin for all 25 isolates, To prove that azithromycin exerts its antifungal effect by inhibiting protein synthesis, we studied [S-35]-methionine incorporation into protein in one Aspergillus isolate. Neither amphotericin B at 0.125 mu g/ml (fourfold below its MIC) nor azithromycin at 16 mu g/ml (greater than or equal to 16-fold below its MIC) had any effect on protein synthesis when tested alone. Upon combination, however, a 68% inhibition in protein synthesis was evident by the inhibition of [S-35]-methionine incorporation.
引用
收藏
页码:846 / 848
页数:3
相关论文
共 15 条
  • [1] ACTIVITY OF AZITHROMYCIN AS A BLOOD SCHIZONTICIDE AGAINST RODENT AND HUMAN PLASMODIA IN-VIVO
    ANDERSEN, SL
    AGER, A
    MCGREEVY, P
    SCHUSTER, BG
    WESCHE, D
    KUSCHNER, R
    OHRT, C
    ELLIS, W
    ROSSAN, R
    BERMAN, J
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (02) : 159 - 161
  • [2] INHIBITION OF CYTOPLASMIC AND ORGANELLAR PROTEIN-SYNTHESIS IN TOXOPLASMA-GONDII - IMPLICATIONS FOR THE TARGET OF MACROLIDE ANTIBIOTICS
    BECKERS, CJM
    ROOS, DS
    DONALD, RGK
    LUFT, BJ
    SCHWAB, JC
    CAO, Y
    JOINER, KA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) : 367 - 376
  • [3] THE PHARMACOKINETICS AND INFLAMMATORY FLUID PENETRATION OF ORALLY-ADMINISTERED AZITHROMYCIN
    COOPER, MA
    NYE, K
    ANDREWS, JM
    WISE, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (04) : 533 - 538
  • [4] COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    DAWSON, K
    PFALLER, M
    ANAISSIE, E
    BRESLIN, B
    DIXON, D
    FOTHERGILL, A
    PAETZNICK, V
    PETER, J
    RINALDI, M
    WALSH, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 314 - 319
  • [5] FLEISCHER S, 1979, METHOD ENZYMOL, V56, P23
  • [6] AZITHROMYCIN CONCENTRATIONS IN SINUS FLUID AND MUCOSA AFTER ORAL-ADMINISTRATION
    KARMA, P
    PUKANDER, J
    PENTTILA, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) : 856 - 859
  • [7] KAZUHIRO T, 1996, ANTIMICROBIAL AGENTS, V40, P2271
  • [8] ANTIMICROBIAL SUSCEPTIBILITY TESTING OF 6 CLINICAL ISOLATES OF ASPERGILLUS
    KITAHARA, M
    SETH, VK
    MEDOFF, G
    KOBAYASHI, GS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (06) : 908 - 914
  • [9] POTENTIATION OF ANTIFUNGAL EFFECTS OF ANTIBIOTICS BY AMPHOTERICIN-B
    KWAN, CN
    KOBAYASHI, GS
    SCHLESSINGER, D
    RASKAS, HJ
    MEDOFF, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (02) : 61 - +
  • [10] ANTIFUNGAL ACTIVITY OF 4 TETRACYCLINE ANALOGS AGAINST CANDIDA-ALBICANS INVITRO - POTENTIATION BY AMPHOTERICIN-B
    LEW, MA
    BECKETT, KM
    LEVIN, MJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (02) : 263 - 270